Xeljanz-H-A-20-1485-C-4214-0017: Assessment report on provisional measures - Article 20
Pharmaceutical
Xeljanz-H-A-20-1485-C-4214-0017: Assessment report on provisional measures - Article 20
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Dosage
Xeljanz-H-A-20-1485-C-4214-0017: Assessment report on provisional measures - Article 20
Strength
Xeljanz-H-A-20-1485-C-4214-0017: Assessment report on provisional measures - Article 20
Pack Size
Xeljanz-H-A-20-1485-C-4214-0017: Assessment report on provisional measures - Article 20
Form
Xeljanz-H-A-20-1485-C-4214-0017: Assessment report on provisional measures - Article 20
Source
European Medicines Agency
Safety Profile
Contraindications
Xeljanz-H-A-20-1485-C-4214-0017: Assessment report on provisional measures - Article 20
Side Effects
Xeljanz-H-A-20-1485-C-4214-0017: Assessment report on provisional measures - Article 20
